| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |